This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
08 September 2015
In the version of this article initially published, IBD was identified as irritable bowel disease, rather than inflammatory bowel disease. The error has been corrected in the HTML and PDF versions of the article.
01 September 2015
In the August 2015 issue, in the article “Microbial cocktails join fecal transplants in IBD treatment trials,” IBD was identified as irritable bowel disease, rather than inflammatory bowel disease. The error has been corrected in the HTML and PDF versions of the article. In the same issue, in the article “Oxitec trials GM sterile moth to combat agricultural infestations,” trials with a genetically modified moth were described as the first to be used in agriculture.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ratner, M. Microbial cocktails join fecal transplants in IBD treatment trials. Nat Biotechnol 33, 787–788 (2015). https://doi.org/10.1038/nbt0815-787
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0815-787
This article is cited by
-
Intrahost evolution of the gut microbiota
Nature Reviews Microbiology (2023)
-
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases
Digestive Diseases and Sciences (2020)
-
Gut microbiota and its implications in small bowel transplantation
Frontiers of Medicine (2018)
-
Bugging inflammation: role of the gut microbiota
Clinical & Translational Immunology (2016)
-
Seres's pioneering microbiome drug fails mid-stage trial
Nature Biotechnology (2016)